Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 16, 2020, titled "Alembic Pharmaceuticals announces USFDA Approval for Amantadine Hydrochloride Tablets, 100 mg.".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 16, 2020, titled "Alembic Pharmaceuticals announces USFDA Approval for Amantadine Hydrochloride Tablets, 100 mg.".